A US Centers for Disease Control and Prevention advisory committee on 21 October recommended use of COVID-19 vaccine booster doses for certain individuals originally vaccinated with Moderna, Inc.’s mRNA vaccine, and all individuals who received Janssen Biotech Inc.’s adenovirus vaccine, but backed away from expressing a preference for use of homologous boosters.
CDC director Rochelle Walensky endorsed the Advisory Committee on Immunization Practices’ favorable recommendations within hours of the meeting’s conclusion. The...







